TraceyMcLaughlinMDMS

Endocrinology • Stanford, CA

Diabetes, Lipid Metabolism

Professor, Medicine - Endocrinology, Gerontology, & Metabolism, Stanford University Medical Center

Join to view full profile

Dr. McLaughlin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. McLaughlin's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Summary

I am a board certified endocrinologist with a sub-specialization in diabetes and metabolism. I see patients with type 1 and type 2 diabetes as well as hypoglycemia, polycystic ovary syndrome, and metabolic syndrome. I conduct clinical research on obesity, diabetes, and metabolism.

Education & Training

Stanford Health Care-Sponsored Stanford UniversityFellowship, Endocrinology, Diabetes, and Metabolism, 1997 - 2000
Santa Clara Valley Medical CenterResidency, Internal Medicine, 1994 - 1997
University of California San Francisco School of MedicineClass of 1994
University of California, BerkeleyMS, Public Health, 1991 - 1992

Certifications & Licensure

CA State Medical License 1995 - 2025
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013

Clinical Trials

Obesity, Weight Loss, and Cardiovascular Disease Risk
COMPLETED
NA
Integrating the Genetic and Metabolic Faces of Obesity
COMPLETED
PHASE1
Adipose Tissue Response to Overfeeding in Insulin Resistance-Prone vs. Insulin Sensitive Humans Start of enrollment: 2011 Sep 01
Completed
Not Applicable
Effect of Liraglutide (Victoza) on Inflammation in Human Adipose Tissue and Blood Start of enrollment: 2015 Jan 01
Completed
Phase 1
Evaluation of Single Ascending Doses of Subcutaneous Exendin 9-39 in Patients With Post-Bariatric Hypoglycemia
COMPLETED
PHASE1
Ertugliflozin: Cardioprotective Effects on Epicardial Fat Start of enrollment: 2020 Jul 01
COMPLETED
EARLY_PHASE1
Role of Nutrient Transit in Hyperinsulinemic Hypoglycemia Start of enrollment: 2020 May 06
RECRUITING
NA
Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia Start of enrollment: 2024 Jan 04
RECRUITING
PHASE2
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Prediction of metabolic subphenotypes of type 2 diabetes via continuous glucose monitoring and machine learning.
Ahmed A Metwally, Dalia Perelman, Heyjun Park, Yue Wu, Alokkumar Jha
Nature Biomedical Engineering. 2024-12-23
1 citations
Predicting Type 2 Diabetes Metabolic Phenotypes Using Continuous Glucose Monitoring and a Machine Learning Framework.
Ahmed A Metwally, Dalia Perelman, Heyjun Park, Yue Wu, Alokkumar Jha
Medrxiv. 2024-09-09
Lifestyle Profiling Using Wearables and Prediction of Glucose Metabolism in Individuals with Normoglycemia or Prediabetes.
Heyjun Park, Ahmed A Metwally, Alireza Delfarah, Yue Wu, Dalia Perelman
Medrxiv. 2024-09-06

Journal Articles

Metabolic Markers, Regional Adiposity, and Adipose Cell Size: Relationship to Insulin Resistance in African-American as Compared with Caucasian Women
Tracey McLaughlin, MD, Nature
Hypoglycemia After Gastric Bypass Surgery: Current Concepts and Controversies
Tracey McLaughlin, Adrian Vella, The Journal of Clinical Endocrinology and Metabolism

Press Mentions

How AI Could Supercharge Your Glucose Monitor - and Catch Other Health IssuesJanuary 13th, 2025
KMN 2025: AI Makes Use of Easy Glucose Monitor Information to Foretell and Determine Subtypes of Kind 2 DiabetesJanuary 9th, 2025
AI Tool Parses Diabetes Subtypes Using Continuous Glucose MonitorsJanuary 8th, 2025
Join now to see all